About Us: Developing expert computer systems and facilitating data-sharing in the life science industries
We accelerate the discovery pipeline of the life sciences industry by enabling scientifically robust decisions to be made faster through advanced analytics which are informed by our position as the industry’s honest broker.
Products and Initiatives
State-of-the-art computer software for the advancement and acceleration of discovery in chemistry and the life sciences. Lhasa software aids in regulatory submission and helps scientists to work more efficiently and effectively, expediting development.
Lhasa is also involved in a variety of collaborative initiatives. Find out more using the links below.
Lhasa Symposia
Lhasa Symposia offer an excellent opportunity for member representatives to join with Lhasa Limited scientists and staff, with the purpose of sharing knowledge and views on scientific issues and Lhasa Limited products.
Each Lhasa Symposium will focus on a different scientific area relevant to the industry at that time.
Your complete solution for the ICH M7 Guidelines
Lhasa Limited can help you to organise the relevant information for an ICH M7 submission. Using the ICH M7 functionality within the Nexus Suite, Derek and Sarah Nexus are brought together to provide the expert rule-based and statistical-based in silico predictions required under ICH M7.
Events
Lhasa Limited regularly attends relevant conferences around the world in order to meet with its members and prospects and to share knowledge and updates. Lhasa also holds its own face-to-face and virtual events.
Publications
Lhasa Limited frequently publishes articles, posters and presentations into its library to ensure its members and prospects are kept up-to-date with research and developments.
-
Retrospective analysis of the potential use of virtual control groups in preclinical toxicity assessment using the eTOX database
January 2023
-
Statistical analysis of preclinical inter-species concordance of histopathological findings in the eTOX database
January 2023
-
Enhancing global and local decision making for chemical safety assessments through increasing the availability of data
January 2023
-
Strategies for Assessing Acceptable Intakes for Novel N-Nitrosamines Derived from Active Pharmaceutical Ingredients
November 2022
News
For recent News and Press Releases from Lhasa Limited, visit our News library.
-
Vitic Excipients data release: sharing data on the effects of pharmaceutical excipients
Jan 30 2023
-
Lhasa Limited announce the launch of innovative solution to support ICH S1 carcinogenicity assessments
Dec 21 2022
-
Lhasa Limited unveil Mirabilis 4 – introducing a conditions-based approach for predicting reactivity, solubility and volatility
Dec 15 2022
-
Lhasa Limited releases new data to Aromatic Amines database users
Dec 15 2022
-
Second release of the complex nitrosamines database announced to members
Dec 6 2022
-
Lhasa Limited announces the anticipated release of Zeneth 9
Nov 30 2022
About LHASA
We accelerate the discovery pipeline of the life sciences industry by enabling scientifically robust decisions to be made faster through advanced analytics which are informed by our position as the industry’s honest broker.
Our technology is uniquely designed by scientists, for scientists, and is developed in collaboration with industry stakeholders and regulators. Our not-for-profit status ensures that our sole focus is helping our members to be successful and thereby delivering public benefit.
Useful links
Staff Profiles
Find out more about our talented staff.
Current Vacancies
Want to work for Lhasa? Check out our careers page.
How to find us
Find out how to get to Lhasa's offices.
What are Lhasa Symposia?
Find out more about Lhasa's Symposia.
